This Thanksgiving, we want to thank everyone who has been part of the Moderna journey and to highlight the many ways they make what we do possible. Happy #Thanksgiving! We are grateful for you!
Moderna
Biotechnology Research
Cambridge, Massachusetts 635,211 followers
Our mission is to deliver the greatest possible impact to people through mRNA medicines.
About us
At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease. Given its essential role, we believe mRNA could be used to create a new category of medicines with significant potential to improve the lives of patients. We are pioneering a new class of medicines made of messenger RNA, or mRNA. The potential implications of using mRNA as a drug are significant and far-reaching and could meaningfully improve how medicines are discovered, developed and manufactured. To learn more, visit www.modernatx.com. This Moderna page is not the appropriate place to report adverse events (side-effects) for any products. If you are or someone you know is experiencing a side effect, please reach out to your healthcare professional. Moderna is continuously monitoring the safety of its products. We encourage you to report any side effects directly to us at 1‑866‑MODERNA (1‑866‑663‑3762).
- Website
-
https://www.modernatx.com/?tc=soc_7y8qkt&cc=1004
External link for Moderna
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Public Company
- Founded
- 2010
- Specialties
- Biotechnology and mRNA Therapeutics
Locations
-
Primary
200 Technology Sq
Cambridge, Massachusetts 02139, US
-
1 Upland Rd
Norwood, Massachusetts 02062, US
Employees at Moderna
-
Jean-Christophe Wüthrich
Business Technology Management | Strategic Planning & IT Governance | Service Management, Integration & Performance | Change Management | Sourcing…
-
Shawn Lipstein
Innovative UX & Product Leader | Critical Thinker | Strategic Visionary | Empathetic Manager | Driven Partner | Crystal Clear Communicator
-
Lukasz Wielochowski
Head of Moderna Enterprise Solution Hub in Poland
-
Karen Doolittle
MBA | PfMP, PgMP, PMP Pharmacovigilance Operations
Updates
-
Cancer impacts so many of us and much is still unknown, but advances in #mRNA technology are unlocking a new era of individualized medicine. Learn more from the Boston Globe Media how we are exploring this groundbreaking approach to potentially transform cancer care. https://lnkd.in/einQUD4t
-
Last season, COVID-19 was still putting more people in the hospital than the flu. In fact, cumulative hospitalization rate for #COVID was almost 2.4 times than that for #flu. An updated vaccine can help protect you and your loved ones – find a vaccine near you: http://foryouandthem.com
-
Congratulations to our Chief Brand Officer Kate Cronin on being inducted into the 2024 #PRWeekHallofFame! 🎉 From leading communications for Moderna to shaping the company’s global brand during one of the most critical times in public health, Kate has played a pivotal role in amplifying Moderna’s story and advocating around the promise of #mRNA science for patients.
What an incredible night celebrating the 2024 PRWeek Hall of Fame inductees! 🎉 We honored industry leaders who have made lasting impacts in PR, including visionaries from Moderna, The Weber Shandwick Collective and more. From heartfelt speeches to unforgettable moments, it was a true celebration of leadership, innovation, and excellence in communications. Huge thanks to everyone who joined us! #PRWeekHallofFame #PRWeekHOF #Leadership #PRExcellence #HallofFame Moderna FleishmanHillard UnitedHealth Group Eli Lilly and Company NBCUniversal Telemundo Enterprises Burson The Weber Shandwick Collective
-
+4
-
Exciting times at The Boston Globe Media's Future of Medicine event last week! We were thrilled to have our Chief Medical Officer, Jacqueline Miller, kick off a powerful panel on the next generation of vaccines. Kyle Holen, our Head of Development for Oncology and Therapeutics, joined forces with experts from Dana-Farber Cancer Institute and Beth Israel Lahey Health for an inspiring discussion on the future of cancer care. A big thank you to Hannah Green from the Boston Business Journal for moderating the panel. Together, we’re exploring groundbreaking advancements that could shape the future of healthcare! #FutureOfMedicine #VaccineInnovation
-
📢 We’re thrilled to welcome Brian Gladsden to Moderna in a new role as the head of Commercial Platforms. Brian will join our Commercial Leadership Team and brings more than 25 years of experience in the biopharmaceutical industry. Most recently he served as CEO of Mosaic Therapeutics, and before that led Worldwide Commercial & Portfolio Strategy for Novartis Oncology. His experience spans global launches across the U.S., Asia Pacific and Europe, and he has successfully led country operations in Japan, Australia, Korea and Austria. Welcome, Brian!
-
Congratulations to our Chief Information Officer Brad Miller for being named to the 2024 #ForbesCIO Next List! 🎉 This prestigious recognition highlights Brad’s innovative leadership in advancing Moderna's mission. By deeply integrating technology into the company's DNA, we are using AI to scale and maximize our impact on patients. Read more: https://lnkd.in/e_bvMijT
The Forbes CIO Next List: 2024
social-www.forbes.com
-
The fall respiratory virus season significantly increases pharmacies' workloads, particularly with the heightened demand for vaccinations – which places an immense pressure on pharmacy teams. Read more from Justin Scholl, a pharmacist in Northwestern Pennsylvania, about some of the challenges and opportunities pharmacists face during this demanding season, along with tips to help pharmacies navigate it effectively: https://lnkd.in/ebrUuTMW
-
For the third consecutive year, we were a Health Equity sponsor of HLTH USA. A key highlight included a fireside chat with Hamilton Bennett, our Senior Director of Vaccine Access and Partnerships and Dr. Nicole Lurie, CEPI’s Executive Director for Preparedness and Response. The conversation highlighted how partnerships are key to building systems, processes, and innovations for effective, equitable pandemic responses. Read more about our presence at the event: https://lnkd.in/eirt3J82
-
We are excited to announce expanded roles of two current members of our Executive Committee! 🎊 Stephen Hoge, M.D., our President, will expand his role to include oversight of the Commercial organization, responsible for strategy across the full product lifecycle from Research and Development, through Medical Affairs and Commercial. Tracey Franklin, our Chief Human Resources Officer, will expand her role to become the Chief People and Digital Technology Officer. The expansion of her role emphasizes the vital integration of people, culture and digital innovation. Congratulations to Stephen and Tracey!